Abstract
Primary and secondary chromosomal abnormalities play an important role in the characterization of biological, pathological, and clinical subgroups of malignant lymphomas. The introduction of fluorescence in situ hybridization (FISH) and the combination of immunophenotyping plus FISH to the diagnosis of lymphatic neoplasms allows the fast and sensitive detection of specific chromosomal changes and provides new insights into the genetic basis of lymphomagenesis. This article reviews the possibilities and limitations of molecular cytogenetic techniques in comparison to cytogenetic and molecular genetic methods and discusses their clinico-pathological impact for non-Hodgkin’s lymphoma and Hodgkin’s disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Accepted: 30 July 1997
Rights and permissions
About this article
Cite this article
Siebert, R., Weber-Matthiesen, K. Fluorescence in situ hybridization as a diagnostic tool in malignant lymphomas. Histochemistry 108, 391–402 (1997). https://doi.org/10.1007/s004180050180
Issue Date:
DOI: https://doi.org/10.1007/s004180050180